Vestcor Inc’s Krystal Biotech KRYS Stock Holding History

Vestcor Inc’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$487K	Hold	1,311	–	–	0.01%	784
2026 Q1	$339K	Buy	+1,311	New	+$349K	0.01%	880

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vestcor Inc's KRYS Position: Q2 2026 in Review

Vestcor Inc held its Krystal Biotech (KRYS) position steady in Q2 2026 at 1,311 shares worth $487K. The position accounts for 0.01% of the portfolio, ranked #784.

Vestcor Inc first reported a position in KRYS in Q1 2026 and has held it in 2 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Vestcor Inc held 1,311 shares of Krystal Biotech worth $487K as of Q2 2026.
Vestcor Inc left its Krystal Biotech share count unchanged in Q2 2026.
Krystal Biotech made up 0.01% of Vestcor Inc's portfolio in Q2 2026, its #784 holding.
Vestcor Inc first reported a position in Krystal Biotech in Q1 2026 and has held it in 2 quarters since.
423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.